Skip to main content

Table 3 Comparison of clobazam treated patients from the study by Sivakumar et al. and the present study

From: Effects of clobazam for treatment of refractory status epilepticus

Variable

Sivakumar et al. (n = 17)

Present study (n = 24)

P value

Age on admission, y

63 (54–70)

64 (52–72)

0.466b

History of seizures

11 (64.7)

10 (41.7)

0.146a

CLB maintenance dose (mg/d)

20 (10–30)

20 (14–23)

0.763b

RSE duration before CLB, d

4 (2–7)

2 (0–9)

0.432b

CLB last AED added to therapy

16 (94.1)

6 (25.0)

<0.001 a

Use of anesthetics

12 (70.6)

11 (45.8)

0.116a

Length of hospital stay, d

30 (17–38)

29 (13–61)

0.672b

  1. Values are n (%), or median (interquartile range); significant (p < 0.05) parameters are expressed in bold
  2. Abbreviations: CLB clobazam, RSE refractory status epilepticus
  3. aPearson χ2 test
  4. bMann-Whitney U-test